Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Get Started Trucks and SUVs for Hauling 2026 GMC Sierra 1500 9,000 lbs towing capacity 2026 Jeep Gladiator 4,500 lbs towing capacity Research Other Trucks and Cars
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
tb burden ( Figures 3F, G )
[PMID: 532501] PubMed record related to this compound for laboratory literature review
Key Benefits: Want to stay younger, longer
10 , e1004271 (2014)
